about
Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central ItalyHCV-HIV coinfected pregnant women: data from a multicentre study in Italy.Pregnancy outcomes in women with advanced HIV infection in Italy.Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia.Impact of pre-therapy viral load on virological response to modern first-line HAART.Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy.Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes.Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.The diabetes-tuberculosis co-epidemic: the role of international migration.An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections.Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based studyPolyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy.Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study.Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.Pregnancy outcomes in HIV-infected women of advanced maternal age.Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.Plasma lipid profile in pregnant women with HIV receiving nevirapine.Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy.Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.Body mass index and weight gain in pregnant women with HIV: a national study in Italy.Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV.Glucose plasma levels and pregnancy outcomes in women with HIV.Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001–2011Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimensRubella Susceptibility Profile in Pregnant Women with HIVGood prenatal detection rate of major birth defects in HIV-infected pregnant women in ItalyImmune Status and Serial Quantiferon-TB Gold In-Tube Screening for LatentMycobacterium tuberculosisInfection Among HIV-Infected Persons in a Country With a Low Tuberculosis IncidencePregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality
P50
Q28547222-CD7CB558-D91E-4151-9419-02246CC8AE9FQ31011972-8D34F944-695F-4D80-8BBA-11541D13775BQ35445035-51219F48-882F-4142-8408-7445F26D9CA4Q35968753-72F634C3-EB84-4E5D-9369-508C1E765791Q38427973-48ACFE60-D79C-47BC-9E21-C5E9A2369291Q38440876-10B9C947-0C42-4533-AA53-14ECB3DE69F5Q38450147-C893DD9D-C2D6-466A-9FED-C2AE56857885Q39648233-0C9A4531-A43B-4D2F-B955-B9587D6B8904Q40683749-5746A646-43B7-41D6-8EC2-3CD3E654D6BEQ40986411-D8B7F41A-DC2A-4B4A-A391-1681BD7C9C60Q40998601-FC2B2797-824E-4371-B74B-A5659A34E5E1Q41465991-DE7C5C1F-0A1E-4E87-A8D2-743822CD2268Q41812338-E7927D22-E686-4616-940A-C89C64A9AE8DQ42208420-CF537746-44CA-43F0-9A8F-F81073F13254Q42209715-3CD2EF3C-AF5A-4332-8FCE-41EC88CA0B90Q42235471-17A59C2C-344C-4D56-9CBA-DBA0702804ECQ42243024-9665164A-EF6F-4D9E-A895-358426D4E964Q42247735-5DA5206C-2D2D-4FD4-AF7B-9FA7B83D3785Q42255965-F0BA2916-452F-4DC1-B7F6-7B1C0E6ED6D9Q42260917-1D58E83E-CC7D-4BA9-951C-4E25D3C25049Q42994549-CACAFB2E-021E-460C-9E95-2E5CEF05E3B9Q43157237-8D80E50D-6857-4C5B-96F4-B84C8F871C54Q43252942-2A9F04C9-4CFF-4F6E-B8D3-7A3583F7BFECQ43470347-79A26635-9B3A-4A61-9AA0-9149B49A3AF6Q44152422-4503F8B7-D77D-450C-AC09-070F626FE401Q44314941-81B129AC-2982-4278-BB71-28F4F889FF9BQ45391845-87A68B4E-C005-4B0B-BDB3-5CFD3FF5A334Q45842769-AD49EBA6-85D9-446F-B192-B60583B53078Q50790868-E261BC34-3C71-4DC6-993C-D6340765808DQ51363612-23D60C34-0254-4158-8D38-BE321E012EACQ56880890-3D57F75B-F9A0-46D8-B6EA-E77EF01CB2D7Q56880892-D34BCA7A-9866-4186-813E-F93447287866Q56880893-0F24F9D4-805B-454A-9FBD-ABA42F815C2DQ56967541-F2C58117-2445-4918-A404-F5B633C1394DQ57632299-BF73D7C5-54A5-4A32-AC2F-B7056681F0C5Q58798108-8C28F659-560C-4E95-AAC1-F3B4BD93AC8B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C Pinnetti
@ast
C Pinnetti
@en
C Pinnetti
@es
C Pinnetti
@nl
C Pinnetti
@sl
type
label
C Pinnetti
@ast
C Pinnetti
@en
C Pinnetti
@es
C Pinnetti
@nl
C Pinnetti
@sl
prefLabel
C Pinnetti
@ast
C Pinnetti
@en
C Pinnetti
@es
C Pinnetti
@nl
C Pinnetti
@sl
P106
P1153
15059521700
P31
P496
0000-0003-1350-4032